Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

  Fractures

  Free Subscription


Articles published in Osteoporos Int

Retrieve available abstracts of 322 articles:
HTML format
Text format



Single Articles


    October 2018
  1. LIU B, Wu Q, Zhang S, Del Rosario A, et al
    Lithium use and risk of fracture: a systematic review and meta-analysis of observational studies.
    Osteoporos Int. 2018 Oct 29. pii: 10.1007/s00198-018-4745.
    PubMed     Text format     Abstract available


  2. YU WB, Jiang XB, Liang D, Xu WX, et al
    Risk factors and score for recollapse of the augmented vertebrae after percutaneous vertebroplasty in osteoporotic vertebral compression fractures.
    Osteoporos Int. 2018 Oct 28. pii: 10.1007/s00198-018-4754.
    PubMed     Text format     Abstract available


  3. YOO J, Lee JS, Kim S, Kim BS, et al
    Length of hospital stay after hip fracture surgery and 1-year mortality.
    Osteoporos Int. 2018 Oct 25. pii: 10.1007/s00198-018-4747.
    PubMed     Text format     Abstract available


  4. LI CY, Chang CL, Tai TW
    Incidence and risk factors for hip fracture in elderly patients undergoing lumbar spine surgery: a nationwide database study with 11-year follow-up.
    Osteoporos Int. 2018 Oct 15. pii: 10.1007/s00198-018-4734.
    PubMed     Text format     Abstract available


  5. WALLANDER M, Axelsson KF, Lundh D, Lorentzon M, et al
    Patients with prostate cancer and androgen deprivation therapy have increased risk of fractures-a study from the fractures and fall injuries in the elderly cohort (FRAILCO).
    Osteoporos Int. 2018 Oct 15. pii: 10.1007/s00198-018-4722.
    PubMed     Text format     Abstract available


  6. ALLAIRE BT, Lu D, Johannesdottir F, Kopperdahl D, et al
    Prediction of incident vertebral fracture using CT-based finite element analysis.
    Osteoporos Int. 2018 Oct 10. pii: 10.1007/s00198-018-4716.
    PubMed     Text format     Abstract available


  7. VILACA T, Walsh J, Eastell R
    Discordant pattern of peripheral fractures in diabetes: a meta-analysis on the risk of wrist and ankle fractures.
    Osteoporos Int. 2018 Oct 10. pii: 10.1007/s00198-018-4717.
    PubMed     Text format     Abstract available


    September 2018
  8. KENDLER DL, Chines A, Brandi ML, Papapoulos S, et al
    The risk of subsequent osteoporotic fractures is decreased in subjects experiencing fracture while on denosumab: results from the FREEDOM and FREEDOM Extension studies.
    Osteoporos Int. 2018 Sep 22. pii: 10.1007/s00198-018-4687.
    PubMed     Text format     Abstract available


  9. MCALISTER FA, Ye C, Beaupre LA, Rowe BH, et al
    Adherence to osteoporosis therapy after an upper extremity fracture: a pre-specified substudy of the C-STOP randomized controlled trial.
    Osteoporos Int. 2018 Sep 19. pii: 10.1007/s00198-018-4702.
    PubMed     Text format     Abstract available


  10. MUNSON JC, Bynum JPW, Bell JE, McDonough C, et al
    Impact of prescription drugs on second fragility fractures among US Medicare patients.
    Osteoporos Int. 2018 Sep 19. pii: 10.1007/s00198-018-4697.
    PubMed     Text format     Abstract available


  11. GAROFOLI R, Maravic M, Ostertag A, Cohen-Solal M, et al
    Secular trends of hip fractures in France: impact of changing characteristics of the background population.
    Osteoporos Int. 2018 Sep 13. pii: 10.1007/s00198-018-4666.
    PubMed     Text format     Abstract available


  12. AL-SARI UA, Tobias JH, Clark EM
    Impact of mild and moderate/severe vertebral fractures on physical activity: a prospective study of older women in the UK.
    Osteoporos Int. 2018 Sep 7. pii: 10.1007/s00198-018-4692.
    PubMed     Text format     Abstract available


    August 2018
  13. LEWIECKI EM, Wright NC, Curtis JR, Siris E, et al
    Correction to: Hip fracture trends in the United States, 2002 to 2015.
    Osteoporos Int. 2018 Aug 27. pii: 10.1007/s00198-018-4685.
    PubMed     Text format     Abstract available


  14. SHIMIZU Y, Sawada N, Nakamura K, Watanabe Y, et al
    Menstrual and reproductive factors and risk of vertebral fractures in Japanese women: the Japan Public Health Center-based prospective (JPHC) study.
    Osteoporos Int. 2018 Aug 24. pii: 10.1007/s00198-018-4665.
    PubMed     Text format     Abstract available


  15. BARZILAY JI, Buzkova P, Cauley JA, Robbins JA, et al
    The associations of subclinical atherosclerotic cardiovascular disease with hip fracture risk and bone mineral density in elderly adults.
    Osteoporos Int. 2018 Aug 21. pii: 10.1007/s00198-018-4611.
    PubMed     Text format     Abstract available


  16. JIANG T, Veres K, Kormendine Farkas D, Lash TL, et al
    Post-traumatic stress disorder and incident fractures in the Danish population.
    Osteoporos Int. 2018 Aug 20. pii: 10.1007/s00198-018-4644.
    PubMed     Text format     Abstract available


  17. VAN DE VEN LI, Klop C, Overbeek JA, de Vries F, et al
    Association between use of antidepressants or benzodiazepines and the risk of subsequent fracture among those aged 65+ in the Netherlands.
    Osteoporos Int. 2018 Aug 15. pii: 10.1007/s00198-018-4632.
    PubMed     Text format     Abstract available


  18. TSUCHIE H, Miyakoshi N, Iba K, Kasukawa Y, et al
    The effects of teriparatide on acceleration of bone healing following atypical femoral fracture: comparison between daily and weekly administration.
    Osteoporos Int. 2018 Aug 13. pii: 10.1007/s00198-018-4658.
    PubMed     Text format     Abstract available


  19. MAZZUCCHELLI R, Crespi Villarias N, Perez Fernandez E, Durban Reguera ML, et al
    Short-term association between outdoor air pollution and osteoporotic hip fracture.
    Osteoporos Int. 2018 Aug 9. pii: 10.1007/s00198-018-4605.
    PubMed     Text format     Abstract available


  20. GIANGREGORIO LM, Gibbs JC, Templeton JA, Adachi JD, et al
    Build better bones with exercise (B3E pilot trial): results of a feasibility study of a multicenter randomized controlled trial of 12 months of home exercise in older women with vertebral fracture.
    Osteoporos Int. 2018 Aug 8. pii: 10.1007/s00198-018-4652.
    PubMed     Text format     Abstract available


  21. ZHANG YS, Weng WY, Xie BC, Meng Y, et al
    Glucagon-like peptide-1 receptor agonists and fracture risk: a network meta-analysis of randomized clinical trials.
    Osteoporos Int. 2018 Aug 6. pii: 10.1007/s00198-018-4649.
    PubMed     Text format     Abstract available


  22. GAMBOA A, Duaso E, Marimon P, Sandiumenge M, et al
    Oral bisphosphonate prescription and non-adherence at 12 months in patients with hip fractures treated in an acute geriatric unit.
    Osteoporos Int. 2018 Aug 3. pii: 10.1007/s00198-018-4622.
    PubMed     Text format     Abstract available


    July 2018
  23. CHO H, Myung J, Suh HS, Kang HY, et al
    Antihistamine use and the risk of injurious falls or fracture in elderly patients: a systematic review and meta-analysis.
    Osteoporos Int. 2018 Jul 25. pii: 10.1007/s00198-018-4564.
    PubMed     Text format     Abstract available


  24. MUNHOZ DA ROCHA LEMOS COSTA T, Costa FM, Hoffman Jonasson T, Aguiar Moreira C, et al
    Bone mineral density and vertebral fractures and their relationship with pulmonary dysfunction in patients with chronic obstructive pulmonary disease.
    Osteoporos Int. 2018 Jul 25. pii: 10.1007/s00198-018-4643.
    PubMed     Text format     Abstract available


  25. HIDAYAT K, Du X, Shi BM
    Sex hormone-binding globulin and risk of fracture in older adults: systematic review and meta-analysis of observational studies.
    Osteoporos Int. 2018 Jul 24. pii: 10.1007/s00198-018-4600.
    PubMed     Text format     Abstract available


  26. LIM SJ, Yeo I, Yoon PW, Yoo JJ, et al
    Incidence, risk factors, and fracture healing of atypical femoral fractures: a multicenter case-control study.
    Osteoporos Int. 2018 Jul 23. pii: 10.1007/s00198-018-4640.
    PubMed     Text format     Abstract available


  27. KYVERNITAKIS I, Kostev K, Hadji P
    The tamoxifen paradox-influence of adjuvant tamoxifen on fracture risk in pre- and postmenopausal women with breast cancer.
    Osteoporos Int. 2018 Jul 21. pii: 10.1007/s00198-018-4642.
    PubMed     Text format     Abstract available


  28. VAN DER VELDE RY, Wyers CE, Geusens PPMM, van den Bergh JPW, et al
    Incidence of subsequent fractures in the UK between 1990 and 2012 among individuals 50 years or older.
    Osteoporos Int. 2018 Jul 20. pii: 10.1007/s00198-018-4636.
    PubMed     Text format     Abstract available


  29. SONG LJ, Wang LL, Ning L, Fan SW, et al
    A modification and validation of quantitative morphometry classification system for osteoporotic vertebral compressive fractures in mainland Chinese.
    Osteoporos Int. 2018 Jul 20. pii: 10.1007/s00198-018-4641.
    PubMed     Text format     Abstract available


  30. KANAZAWA I, Notsu M, Miyake H, Tanaka K, et al
    Assessment using serum insulin-like growth factor-I and bone mineral density is useful for detecting prevalent vertebral fractures in patients with type 2 diabetes mellitus.
    Osteoporos Int. 2018 Jul 20. pii: 10.1007/s00198-018-4638.
    PubMed     Text format     Abstract available


  31. LIU J, Guo H, Rai P, Pinto L, et al
    Medication persistence and risk of fracture among female Medicare beneficiaries diagnosed with osteoporosis.
    Osteoporos Int. 2018 Jul 18. pii: 10.1007/s00198-018-4630.
    PubMed     Text format     Abstract available


  32. BERGMAN J, Nordstrom A, Nordstrom P
    Bisphosphonate use after clinical fracture and risk of new fracture: response to comments by Wu et al.
    Osteoporos Int. 2018 Jul 16. pii: 10.1007/s00198-018-4615.
    PubMed     Text format    


  33. SOGAARD AJ, Ranhoff AH, Meyer HE, Omsland TK, et al
    The association between alcohol consumption and risk of hip fracture differs by age and gender in Cohort of Norway: a NOREPOS study.
    Osteoporos Int. 2018 Jul 13. pii: 10.1007/s00198-018-4627.
    PubMed     Text format     Abstract available


  34. CHRISTIANSEN BA, Harrison SL, Fink HA, Lane NE, et al
    Incident fracture is associated with a period of accelerated loss of hip BMD: the Study of Osteoporotic Fractures.
    Osteoporos Int. 2018 Jul 10. pii: 10.1007/s00198-018-4606.
    PubMed     Text format     Abstract available


  35. WU QY, Yuan FL, Wang B, Li X, et al
    Comments on Bergman et al.: Bisphosphonate use after clinical fracture and risk of new fracture.
    Osteoporos Int. 2018 Jul 5. pii: 10.1007/s00198-018-4614.
    PubMed     Text format    


    June 2018
  36. DESBIENS LC, Sidibe A, Ung RV, Fortier C, et al
    FGF23-klotho axis, bone fractures, and arterial stiffness in dialysis: a case-control study.
    Osteoporos Int. 2018 Jun 29. pii: 10.1007/s00198-018-4598.
    PubMed     Text format     Abstract available


  37. HANSEN L, Judge A, Javaid MK, Cooper C, et al
    Social inequality and fractures-secular trends in the Danish population: a case-control study.
    Osteoporos Int. 2018 Jun 26. pii: 10.1007/s00198-018-4603.
    PubMed     Text format     Abstract available


  38. GIORDANO S, Proietti A, Bisaccia T, Caso P, et al
    Hypovitaminosis D: comparison between patients with hip fracture and patients with vertebral fractures.
    Osteoporos Int. 2018 Jun 23. pii: 10.1007/s00198-018-4582.
    PubMed     Text format     Abstract available


  39. SZAFORS P, Che H, Barnetche T, Morel J, et al
    Risk of fracture and low bone mineral density in adults with inflammatory bowel diseases. A systematic literature review with meta-analysis.
    Osteoporos Int. 2018 Jun 16. pii: 10.1007/s00198-018-4586.
    PubMed     Text format     Abstract available


  40. CHEN H, Lips P, Vervloet MG, van Schoor NM, et al
    Association of renal function with bone mineral density and fracture risk in the Longitudinal Aging Study Amsterdam.
    Osteoporos Int. 2018 Jun 15. pii: 10.1007/s00198-018-4592.
    PubMed     Text format     Abstract available


  41. MOZAFFARI H, Djafarian K, Mofrad MD, Shab-Bidar S, et al
    Dietary fat, saturated fatty acid, and monounsaturated fatty acid intakes and risk of bone fracture: a systematic review and meta-analysis of observational studies.
    Osteoporos Int. 2018 Jun 12. pii: 10.1007/s00198-018-4540.
    PubMed     Text format     Abstract available


  42. KANIS JA, Johansson H, Oden A, Harvey NC, et al
    Characteristics of recurrent fractures.
    Osteoporos Int. 2018 Jun 12. pii: 10.1007/s00198-018-4502.
    PubMed     Text format     Abstract available


  43. BISCHOFF-FERRARI HA, Dawson-Hughes B, Willett WC
    Issues of trial selection and subgroup considerations in the recent meta-analysis of Zhao and colleagues on fracture reduction by calcium and vitamin D supplementation in community-dwelling older adults.
    Osteoporos Int. 2018 Jun 12. pii: 10.1007/s00198-018-4587.
    PubMed     Text format     Abstract available


  44. GUPTA MJ, Shah S, Peterson S, Baim S, et al
    Rush Fracture Liaison Service for capturing "missed opportunities" to treat osteoporosis in patients with fragility fractures.
    Osteoporos Int. 2018 Jun 4. pii: 10.1007/s00198-018-4559.
    PubMed     Text format     Abstract available


  45. RIKKONEN T, Poole K, Sirola J, Sund R, et al
    Long-term effects of functional impairment on fracture risk and mortality in postmenopausal women.
    Osteoporos Int. 2018 Jun 2. pii: 10.1007/s00198-018-4588.
    PubMed     Text format     Abstract available


  46. LOSADA E, Soldevila B, Ali MS, Martinez-Laguna D, et al
    Real-world antidiabetic drug use and fracture risk in 12,277 patients with type 2 diabetes mellitus: a nested case-control study.
    Osteoporos Int. 2018 Jun 2. pii: 10.1007/s00198-018-4581.
    PubMed     Text format     Abstract available


  47. CARLSON BC, Robinson WA, Wanderman NR, Nassr AN, et al
    The American Orthopaedic Association's Own the Bone(R) database: a national quality improvement project for the treatment of bone health in fragility fracture patients.
    Osteoporos Int. 2018 Jun 1. pii: 10.1007/s00198-018-4585.
    PubMed     Text format     Abstract available


  48. JAIN RK, Vokes T
    Association of trabecular bone score (TBS) and prior fracture differs among minorities in NHANES 2005-2008.
    Osteoporos Int. 2018 Jun 1. pii: 10.1007/s00198-018-4584.
    PubMed     Text format     Abstract available


  49. KIM SJ, Park HS, Lee DW, Lee JW, et al
    Is calcium phosphate augmentation a viable option for osteoporotic hip fractures?
    Osteoporos Int. 2018 Jun 1. pii: 10.1007/s00198-018-4572.
    PubMed     Text format     Abstract available


    May 2018
  50. UGLAND TO, Haugeberg G, Svenningsen S, Ugland SH, et al
    Biomarkers of muscle damage increased in anterolateral compared to direct lateral approach to the hip in hemiarthroplasty: no correlation with clinical outcome : Short-term analysis of secondary outcomes from a randomized clinical trial in patients wi
    Osteoporos Int. 2018 May 22. pii: 10.1007/s00198-018-4557.
    PubMed     Text format     Abstract available


  51. VOETEN SC, Krijnen P, Voeten DM, Hegeman JH, et al
    Quality indicators for hip fracture care, a systematic review.
    Osteoporos Int. 2018 May 17. pii: 10.1007/s00198-018-4558.
    PubMed     Text format     Abstract available


  52. GENEST F, Seefried L
    Subtrochanteric and diaphyseal femoral fractures in hypophosphatasia-not atypical at all.
    Osteoporos Int. 2018 May 17. pii: 10.1007/s00198-018-4552.
    PubMed     Text format     Abstract available


  53. SU Y, Lai FTT, Yip BHK, Leung JCS, et al
    Cost-effectiveness of osteoporosis screening strategies for hip fracture prevention in older Chinese people: a decision tree modeling study in the Mr. OS and Ms. OS cohort in Hong Kong.
    Osteoporos Int. 2018 May 17. pii: 10.1007/s00198-018-4543.
    PubMed     Text format     Abstract available


  54. NGUYEN ET, Posas-Mendoza T, Siu AM, Ahn HJ, et al
    Low rates of osteoporosis treatment after hospitalization for hip fracture in Hawaii.
    Osteoporos Int. 2018 May 9. pii: 10.1007/s00198-018-4553.
    PubMed     Text format     Abstract available


    April 2018
  55. INDERJEETH CA, Raymond WD, Briggs AM, Geelhoed E, et al
    Implementation of the Western Australian Osteoporosis Model of Care: a fracture liaison service utilising emergency department information systems to identify patients with fragility fracture to improve current practice and reduce re-fracture rates: a
    Osteoporos Int. 2018 Apr 27. pii: 10.1007/s00198-018-4526.
    PubMed     Text format     Abstract available


  56. DELL R, Greene D
    A proposal for an atypical femur fracture treatment and prevention clinical practice guideline.
    Osteoporos Int. 2018 Apr 19. pii: 10.1007/s00198-018-4506.
    PubMed     Text format     Abstract available


  57. BENETOU V, Orfanos P, Feskanich D, Michaelsson K, et al
    Mediterranean diet and hip fracture incidence among older adults: the CHANCES project.
    Osteoporos Int. 2018 Apr 14. pii: 10.1007/s00198-018-4517.
    PubMed     Text format     Abstract available


  58. YIN P, Lv H, Li Y, Meng Y, et al
    Hip fracture patients who experience a greater fluctuation in RDW during hospital course are at heightened risk for all-cause mortality: a prospective study with 2-year follow-up.
    Osteoporos Int. 2018 Apr 14. pii: 10.1007/s00198-018-4516.
    PubMed     Text format     Abstract available


  59. SU Y, Leung J, Kwok T
    The role of previous falls in major osteoporotic fracture prediction in conjunction with FRAX in older Chinese men and women: the Mr. OS and Ms. OS cohort study in Hong Kong.
    Osteoporos Int. 2018 Apr 12. pii: 10.1007/s00198-017-4373.
    PubMed     Text format     Abstract available


  60. CLARK EM, Gooberman-Hill R, Peters TJ
    Correction to: Using self-reports of pain and other variables to distinguish between older women with back pain due to vertebral fractures and those with back pain due to degenerative changes.
    Osteoporos Int. 2018 Apr 12. pii: 10.1007/s00198-018-4495.
    PubMed     Text format     Abstract available


  61. WANG MQ, Youssef T, Smerdely P
    Incidence and outcomes of humeral fractures in the older person.
    Osteoporos Int. 2018 Apr 4. pii: 10.1007/s00198-018-4500.
    PubMed     Text format     Abstract available


  62. ZHU JJ, Mahendran D, Lee MH, Seah J, et al
    Systemic mastocytosis identified in two women developing fragility fractures during lactation.
    Osteoporos Int. 2018 Apr 4. pii: 10.1007/s00198-018-4498.
    PubMed     Text format     Abstract available


    March 2018
  63. XIAO X, Xu Y, Wu Q
    Thiazide diuretic usage and risk of fracture: a meta-analysis of cohort studies.
    Osteoporos Int. 2018 Mar 25. pii: 10.1007/s00198-018-4486.
    PubMed     Text format     Abstract available


  64. PASKINS Z, Whittle R, Abdul Sultan A, Muller S, et al
    Risk of fragility fracture among patients with late-onset psoriasis: a UK population-based study.
    Osteoporos Int. 2018 Mar 24. pii: 10.1007/s00198-018-4491.
    PubMed     Text format     Abstract available


  65. UNGPRASERT P, Crowson CS, Matteson EL
    Risk of fragility fracture among patients with sarcoidosis: a population-based study 1976-2013-supplementary presentation.
    Osteoporos Int. 2018 Mar 22. pii: 10.1007/s00198-017-4074.
    PubMed     Text format     Abstract available


  66. GRAUMAM RQ, Pinheiro MM, Nery LE, Castro CHM, et al
    Increased rate of osteoporosis, low lean mass, and fragility fractures in COPD patients: association with disease severity.
    Osteoporos Int. 2018 Mar 21. pii: 10.1007/s00198-018-4483.
    PubMed     Text format     Abstract available


  67. ALEKSOVA J, Kurniawan S, Elder GJ
    The trabecular bone score is associated with bone mineral density, markers of bone turnover and prevalent fracture in patients with end stage kidney disease.
    Osteoporos Int. 2018 Mar 19. pii: 10.1007/s00198-018-4468.
    PubMed     Text format     Abstract available


  68. JIN S, Hsieh E, Peng L, Yu C, et al
    Incidence of fractures among patients with rheumatoid arthritis: a systematic review and meta-analysis.
    Osteoporos Int. 2018 Mar 15. pii: 10.1007/s00198-018-4473.
    PubMed     Text format     Abstract available


  69. WU Q, Liu B, Tonmoy S
    Depression and risk of fracture and bone loss: an updated meta-analysis of prospective studies.
    Osteoporos Int. 2018 Mar 12. pii: 10.1007/s00198-018-4420.
    PubMed     Text format     Abstract available


  70. WU CH, Chen CH, Chen PH, Yang JJ, et al
    Identifying characteristics of an effective fracture liaison service: systematic literature review.
    Osteoporos Int. 2018 Mar 10. pii: 10.1007/s00198-017-4370.
    PubMed     Text format     Abstract available


  71. NURMI-LUTHJE I, Tiihonen R, Paattiniemi EL, Naboulsi H, et al
    Correction to: Remarkable improvement in serum 25-hydroxyvitamin levels among hip fracture patients over a 12-year period: a prospective study in South-eastern Finland.
    Osteoporos Int. 2018 Mar 5. pii: 10.1007/s00198-018-4432.
    PubMed     Text format     Abstract available


  72. BYBERG L, Michaelsson K
    Comments on Feskanich et al.: Milk and other dairy foods and risk of hip fracture in men and women.
    Osteoporos Int. 2018 Mar 2. pii: 10.1007/s00198-018-4397.
    PubMed     Text format    


  73. ZHANG Y, Hao Q, Ge M, Dong B, et al
    Association of sarcopenia and fractures in community-dwelling older adults: a systematic review and meta-analysis of cohort studies.
    Osteoporos Int. 2018 Mar 2. pii: 10.1007/s00198-018-4429.
    PubMed     Text format     Abstract available


    February 2018
  74. PACCOU J, D'Angelo S, Rhodes A, Curtis EM, et al
    Prior fragility fracture and risk of incident ischaemic cardiovascular events: results from UK Biobank.
    Osteoporos Int. 2018 Feb 26. pii: 10.1007/s00198-018-4426.
    PubMed     Text format     Abstract available


  75. UEI H, Tokuhashi Y, Maseda M, Nakahashi M, et al
    Multiple vertebral fractures associated with glucocorticoid-induced osteoporosis treated with teriparatide followed by kyphosis correction fusion: a case report.
    Osteoporos Int. 2018 Feb 23. pii: 10.1007/s00198-018-4425.
    PubMed     Text format     Abstract available


  76. GUIRANT L, Carlos F, Curiel D, Kanis JA, et al
    Health-related quality of life during the first year after a hip fracture: results of the Mexican arm of the International Cost and Utility Related to Osteoporotic Fractures Study (MexICUROS).
    Osteoporos Int. 2018 Feb 20. pii: 10.1007/s00198-018-4389.
    PubMed     Text format     Abstract available


  77. KUIPER BW, Graybill S, Tate JM, Kaufman N, et al
    After the fall: improving osteoporosis treatment following hip fracture.
    Osteoporos Int. 2018 Feb 20. pii: 10.1007/s00198-018-4416.
    PubMed     Text format     Abstract available


  78. LEE CK, Choi SK, Shin DA, Yi S, et al
    Parkinson's disease and the risk of osteoporotic vertebral compression fracture: a nationwide population-based study.
    Osteoporos Int. 2018 Feb 19. pii: 10.1007/s00198-018-4409.
    PubMed     Text format     Abstract available


  79. WU CH, Kao IJ, Hung WC, Lin SC, et al
    Economic impact and cost-effectiveness of fracture liaison services: a systematic review of the literature.
    Osteoporos Int. 2018 Feb 19. pii: 10.1007/s00198-018-4411.
    PubMed     Text format     Abstract available


  80. BINKLEY N, Krueger D, de Papp AE
    Multiple vertebral fractures following osteoporosis treatment discontinuation: a case-report after long-term Odanacatib.
    Osteoporos Int. 2018 Feb 18. pii: 10.1007/s00198-018-4385.
    PubMed     Text format     Abstract available


  81. GHEORGHITA A, Webster F, Thielke S, Sale JEM, et al
    Long-term experiences of pain after a fragility fracture.
    Osteoporos Int. 2018 Feb 17. pii: 10.1007/s00198-018-4399.
    PubMed     Text format     Abstract available


  82. ROUX S, Gaboury I, Gionet-Landry N, Garant MP, et al
    Using a sequential explanatory mixed method to evaluate the therapeutic window of opportunity for initiating osteoporosis treatment following fragility fractures.
    Osteoporos Int. 2018 Feb 14. pii: 10.1007/s00198-017-4374.
    PubMed     Text format     Abstract available


  83. GREENSPAN SL, Singer A, Vujevich K, Marchand B, et al
    Implementing a fracture liaison service open model of care utilizing a cloud-based tool.
    Osteoporos Int. 2018 Feb 10. pii: 10.1007/s00198-017-4371.
    PubMed     Text format     Abstract available


  84. PRZEDLACKI J, Buczynska-Chyl J, Kozminski P, Niemczyk E, et al
    The utility of FRAX(R) in predicting bone fractures in patients with chronic kidney disease on hemodialysis: a two-year prospective multicenter cohort study.
    Osteoporos Int. 2018 Feb 6. pii: 10.1007/s00198-018-4406.
    PubMed     Text format     Abstract available


  85. BERGMAN J, Nordstrom A, Nordstrom P
    Bisphosphonate use after clinical fracture and risk of new fracture.
    Osteoporos Int. 2018 Feb 3. pii: 10.1007/s00198-017-4367.
    PubMed     Text format     Abstract available


    January 2018
  86. KLINGBERG S, Mehlig K, Sundh V, Heitmann BL, et al
    Lower risk of hip fractures among Swedish women with large hips?
    Osteoporos Int. 2018 Jan 27. pii: 10.1007/s00198-017-4363.
    PubMed     Text format     Abstract available


  87. WRIGHT NC, Hooker ER, Nielson CM, Ensrud KE, et al
    The epidemiology of wrist fractures in older men: the Osteoporotic Fractures in Men (MrOS) study.
    Osteoporos Int. 2018 Jan 17. pii: 10.1007/s00198-017-4349.
    PubMed     Text format     Abstract available


  88. JOHANSSON H, Hongslo Vala C, Oden A, Lorentzon M, et al
    Low risk for hip fracture and high risk for hip arthroplasty due to osteoarthritis among Swedish farmers.
    Osteoporos Int. 2018 Jan 12. pii: 10.1007/s00198-017-4355.
    PubMed     Text format     Abstract available


    December 2017
  89. CHANG Y-, Huang C-, Hwang J-, Kuo J-, et al
    Fracture liaison services for osteoporosis in the Asia-Pacific region: current unmet needs and systematic literature review.
    Osteoporos Int. 2017 Dec 28. pii: 10.1007/s00198-017-4347.
    PubMed     Text format     Abstract available


  90. MICHAEL LEWIECKI E, Wright NC, Curtis JR, Siris E, et al
    Hip fracture trends in the United States, 2002 to 2015.
    Osteoporos Int. 2017 Dec 27. pii: 10.1007/s00198-017-4345.
    PubMed     Text format     Abstract available


  91. TAMIMI I, Nicolau B, Eimar H, Arekunnath Madathil S, et al
    Acetylcholinesterase inhibitors and the risk of osteoporotic fractures: nested case-control study.
    Osteoporos Int. 2017 Dec 20. pii: 10.1007/s00198-017-4346.
    PubMed     Text format     Abstract available


  92. VAN DEN BERG P, van Haard PMM, van der Veer E, Geusens PP, et al
    A dedicated Fracture Liaison Service telephone program and use of bone turnover markers for evaluating 1-year persistence with oral bisphosphonates.
    Osteoporos Int. 2017 Dec 19. pii: 10.1007/s00198-017-4340.
    PubMed     Text format     Abstract available


  93. LUTHMAN S, Widen J, Borgstrom F
    Appropriateness criteria for treatment of osteoporotic vertebral compression fractures.
    Osteoporos Int. 2017 Dec 19. pii: 10.1007/s00198-017-4348.
    PubMed     Text format     Abstract available


  94. NURMI-LUTHJE I, Tiihonen R, Paattiniemi EL, Naboulsi H, et al
    Remarkable improvement in serum 25-hydroxyvitamin levels among hip fracture patients over a 12-year period: a prospective study in South-eastern Finland.
    Osteoporos Int. 2017 Dec 19. pii: 10.1007/s00198-017-4344.
    PubMed     Text format     Abstract available


  95. NIIMI R, Kono T, Nishihara A, Hasegawa M, et al
    Rebound-associated vertebral fractures after discontinuation of denosumab for the treatment of maxillitis.
    Osteoporos Int. 2017 Dec 11. pii: 10.1007/s00198-017-4334.
    PubMed     Text format     Abstract available


  96. SVEDBOM A, Borgstom F, Hernlund E, Strom O, et al
    Quality of life for up to 18 months after low-energy hip, vertebral, and distal forearm fractures-results from the ICUROS.
    Osteoporos Int. 2017 Dec 11. pii: 10.1007/s00198-017-4317.
    PubMed     Text format     Abstract available


  97. WATANABE R, Shiraki M, Saito M, Okazaki R, et al
    Restrictive pulmonary dysfunction is associated with vertebral fractures and bone loss in elderly postmenopausal women.
    Osteoporos Int. 2017 Dec 7. pii: 10.1007/s00198-017-4337.
    PubMed     Text format     Abstract available


  98. SHEEHAN KJ, Filliter C, Sobolev B, Levy AR, et al
    Time to surgery after hip fracture across Canada by timing of admission.
    Osteoporos Int. 2017 Dec 6. pii: 10.1007/s00198-017-4333.
    PubMed     Text format     Abstract available


    November 2017
  99. BREDEMEIER M
    Comments on Mignot et al.: bisphosphonate drug holidays in postmenopausal osteoporosis: effect on clinical fracture risk.
    Osteoporos Int. 2017 Nov 27. pii: 10.1007/s00198-017-4263.
    PubMed     Text format    


  100. PACCOU J, Cortet B
    Bisphosphonate drug holidays in postmenopausal osteoporosis: effect on clinical fracture risk. Response to comments by Bredemeier.
    Osteoporos Int. 2017 Nov 27. pii: 10.1007/s00198-017-4320.
    PubMed     Text format    


  101. VRANKEN L, Wyers CE, Van der Velde RY, Janzing HM, et al
    Comorbidities and medication use in patients with a recent clinical fracture at the Fracture Liaison Service.
    Osteoporos Int. 2017 Nov 23. pii: 10.1007/s00198-017-4290.
    PubMed     Text format     Abstract available


  102. WATANABE R, Tai N, Hirano J, Ban Y, et al
    Independent association of bone mineral density and trabecular bone score to vertebral fracture in male subjects with chronic obstructive pulmonary disease.
    Osteoporos Int. 2017 Nov 22. doi: 10.1007/s00198-017-4314.
    PubMed     Text format     Abstract available


  103. YANG L, Parimi N, Orwoll ES, Black DM, et al
    Association of incident hip fracture with the estimated femoral strength by finite element analysis of DXA scans in the Osteoporotic Fractures in Men (MrOS) study.
    Osteoporos Int. 2017 Nov 22. doi: 10.1007/s00198-017-4319.
    PubMed     Text format     Abstract available


  104. CHRISTOFFERSEN T, Emaus N, Dennison E, Furberg AS, et al
    The association between childhood fractures and adolescence bone outcomes: a population-based study, the Tromso Study, Fit Futures.
    Osteoporos Int. 2017 Nov 16. doi: 10.1007/s00198-017-4300.
    PubMed     Text format     Abstract available


  105. ROZENTAL TD, Johannesdottir F, Walley KC, Bouxsein ML, et al
    Correction to: Characterization of trabecular bone microstructure in premenopausal women with distal radius fractures.
    Osteoporos Int. 2017 Nov 16. doi: 10.1007/s00198-017-4311.
    PubMed     Text format     Abstract available


  106. JOHANSSON L, Sundh D, Nilsson M, Mellstrom D, et al
    Vertebral fractures and their association with health-related quality of life, back pain and physical function in older women.
    Osteoporos Int. 2017 Nov 15. doi: 10.1007/s00198-017-4296.
    PubMed     Text format     Abstract available


  107. SCHONENBERG D, Guggenberger R, Frey D, Pape HC, et al
    CT-based evaluation of volumetric bone density in fragility fractures of the pelvis-a matched case-control analysis.
    Osteoporos Int. 2017 Nov 13. doi: 10.1007/s00198-017-4307.
    PubMed     Text format     Abstract available


  108. SUN Y, Liu C, Bo Y, You J, et al
    Dietary vitamin C intake and the risk of hip fracture: a dose-response meta-analysis.
    Osteoporos Int. 2017 Nov 3. doi: 10.1007/s00198-017-4284.
    PubMed     Text format     Abstract available


  109. ROZENTAL TD, Johannesdottir F, Kempland KC, Bouxsein ML, et al
    Characterization of trabecular bone microstructure in premenopausal women with distal radius fractures.
    Osteoporos Int. 2017 Nov 3. doi: 10.1007/s00198-017-4293.
    PubMed     Text format     Abstract available


  110. AL-SARI UA, Tobias JH, Clark EM
    Self-reported everyday physical activities in older people with osteoporotic vertebral fractures: a systematic review and meta-analysis.
    Osteoporos Int. 2017 Nov 3. doi: 10.1007/s00198-017-4287.
    PubMed     Text format     Abstract available


  111. KAZE AD, Rosen HN, Paik JM
    A meta-analysis of the association between body mass index and risk of vertebral fracture.
    Osteoporos Int. 2017 Nov 3. doi: 10.1007/s00198-017-4294.
    PubMed     Text format     Abstract available


    October 2017
  112. SCHOUSBOE JT, Vo TN, Langsetmo L, Taylor BC, et al
    Predictors of change of trabecular bone score (TBS) in older men: results from the Osteoporotic Fractures in Men (MrOS) Study.
    Osteoporos Int. 2017 Oct 31. doi: 10.1007/s00198-017-4273.
    PubMed     Text format     Abstract available


  113. GREENSPAN SL, Vujevich K, Britton C, Herradura A, et al
    Teriparatide for treatment of patients with bisphosphonate-associated atypical fracture of the femur.
    Osteoporos Int. 2017 Oct 30. doi: 10.1007/s00198-017-4286.
    PubMed     Text format     Abstract available


  114. FESKANICH D, Meyer HE, Fung TT, Bischoff-Ferrari HA, et al
    Milk and other dairy foods and risk of hip fracture in men and women.
    Osteoporos Int. 2017 Oct 27. doi: 10.1007/s00198-017-4285.
    PubMed     Text format     Abstract available


  115. RATHBUN AM, Magaziner J, Shardell MD, Yerges-Armstrong LM, et al
    Older men who sustain a hip fracture experience greater declines in bone mineral density at the contralateral hip than non-fractured comparators.
    Osteoporos Int. 2017 Oct 24. doi: 10.1007/s00198-017-4280.
    PubMed     Text format     Abstract available


  116. SU Y, Leung J, Kwok T
    The role of previous falls in major osteoporotic fracture prediction in conjunction with FRAX in older Chinese men and women: the Mr. OS and Ms. OS cohort study in Hong Kong.
    Osteoporos Int. 2017 Oct 24. doi: 10.1007/s00198-017-4277.
    PubMed     Text format     Abstract available


  117. LIN SM, Yang SH, Liang CC, Huang HK, et al
    Proton pump inhibitor use and the risk of osteoporosis and fracture in stroke patients: a population-based cohort study.
    Osteoporos Int. 2017 Oct 14. doi: 10.1007/s00198-017-4262.
    PubMed     Text format     Abstract available


  118. BINKLEY N, Besuyen R, Fuerst T, Skillern L, et al
    Is drug-induced bone loss acceptable in premenopausal women? A practical fracture risk modeling exercise.
    Osteoporos Int. 2017 Oct 10. doi: 10.1007/s00198-017-4258.
    PubMed     Text format     Abstract available


  119. VERONESE N, Stubbs B, Koyanagi A, Hebert JR, et al
    Pro-inflammatory dietary pattern is associated with fractures in women: an eight-year longitudinal cohort study.
    Osteoporos Int. 2017 Oct 10. doi: 10.1007/s00198-017-4251.
    PubMed     Text format     Abstract available


  120. RODRIGUEZ AJ, Scott D, Ebeling PR
    Comments on Li et al.: Meta-analysis of hypertension and osteoporotic fracture risk in women and men.
    Osteoporos Int. 2017 Oct 6. doi: 10.1007/s00198-017-4246.
    PubMed     Text format    


  121. LI C, Wang Q
    Meta-analysis of hypertension and osteoporotic fracture risk in women and men: response to comments by Rodriguez et al.
    Osteoporos Int. 2017 Oct 6. doi: 10.1007/s00198-017-4245.
    PubMed     Text format    


  122. YANG S, Leslie WD, Luo Y, Goertzen AL, et al
    Automated DXA-based finite element analysis for hip fracture risk stratification: a cross-sectional study.
    Osteoporos Int. 2017 Oct 6. doi: 10.1007/s00198-017-4232.
    PubMed     Text format     Abstract available


  123. VOGIATZI MG, Li D, Tian L, Garifallou JP, et al
    A novel dominant COL11A1 mutation in a child with Stickler syndrome type II is associated with recurrent fractures.
    Osteoporos Int. 2017 Oct 3. doi: 10.1007/s00198-017-4229.
    PubMed     Text format     Abstract available


    September 2017
  124. FREDERIKSEN A, Abrahamsen B, Johansen PB, Sorensen HA, et al
    Danish, national cross-sectional observational study on the prevalence of prior major osteoporotic fractures in adults presenting with hip fracture-limitations and scope for fracture liaison services in prevention of hip fracture.
    Osteoporos Int. 2017 Sep 30. doi: 10.1007/s00198-017-4247.
    PubMed     Text format     Abstract available


  125. BHIMJIYANI A, Neuburger J, Jones T, Ben-Shlomo Y, et al
    The effect of social deprivation on hip fracture incidence in England has not changed over 14 years: an analysis of the English Hospital Episodes Statistics (2001-2015).
    Osteoporos Int. 2017 Sep 30. doi: 10.1007/s00198-017-4238.
    PubMed     Text format     Abstract available


  126. KYVERNITAKIS I, Reuter TC, Hellmeyer L, Hars O, et al
    Subsequent fracture risk of women with pregnancy and lactation-associated osteoporosis after a median of 6 years of follow-up.
    Osteoporos Int. 2017 Sep 30. doi: 10.1007/s00198-017-4239.
    PubMed     Text format     Abstract available


  127. HOLLOWAY KL, Mohebbi M, Betson AG, Hans D, et al
    Prediction of major osteoporotic and hip fractures in Australian men using FRAX scores adjusted with trabecular bone score.
    Osteoporos Int. 2017 Sep 23. doi: 10.1007/s00198-017-4226.
    PubMed     Text format     Abstract available


  128. WRIGHT NC, Saag KG, Dawson-Hughes B, Khosla S, et al
    The impact of the new National Bone Health Alliance (NBHA) diagnostic criteria on the prevalence of osteoporosis in the United States: supplementary presentation.
    Osteoporos Int. 2017 Sep 21. doi: 10.1007/s00198-017-4207.
    PubMed     Text format     Abstract available


  129. STENEVI LUNDGREN S, Rosengren BE, Dencker M, Nilsson JA, et al
    Low physical activity is related to clustering of risk factors for fracture-a 2-year prospective study in children.
    Osteoporos Int. 2017 Sep 15. doi: 10.1007/s00198-017-4203.
    PubMed     Text format     Abstract available


  130. BRIOT K, Geusens P, Em Bultink I, Lems WF, et al
    Inflammatory diseases and bone fragility.
    Osteoporos Int. 2017 Sep 15. doi: 10.1007/s00198-017-4189.
    PubMed     Text format     Abstract available


  131. ANSARI H, Beaton DE, Sujic R, Rotondi NK, et al
    Equal treatment: no evidence of gender inequity in osteoporosis management in a coordinator-based fragility fracture screening program.
    Osteoporos Int. 2017 Sep 10. doi: 10.1007/s00198-017-4206.
    PubMed     Text format     Abstract available


  132. LAROCHE M, Talibart M, Cormier C, Roux C, et al
    Pregnancy-related fractures: a retrospective study of a French cohort of 52 patients and review of the literature.
    Osteoporos Int. 2017 Sep 6. doi: 10.1007/s00198-017-4165.
    PubMed     Text format     Abstract available


  133. KAEWBOONCHOO O, Sung FC, Lin CL, Hsu HC, et al
    Hip fracture risk in patients with burn injury: a retrospective cohort study in Taiwan.
    Osteoporos Int. 2017 Sep 5. doi: 10.1007/s00198-017-4209.
    PubMed     Text format     Abstract available


  134. MIGNOT MA, Taisne N, Legroux I, Cortet B, et al
    Bisphosphonate drug holidays in postmenopausal osteoporosis: effect on clinical fracture risk.
    Osteoporos Int. 2017 Sep 5. doi: 10.1007/s00198-017-4215.
    PubMed     Text format     Abstract available


  135. PEDERSEN AB, Ehrenstein V, Szepligeti SK, Sorensen HT, et al
    Excess risk of venous thromboembolism in hip fracture patients and the prognostic impact of comorbidity.
    Osteoporos Int. 2017 Sep 5. doi: 10.1007/s00198-017-4213.
    PubMed     Text format     Abstract available


  136. ROTHMANN MJ, Moller S, Holmberg T, Hojberg M, et al
    Non-participation in systematic screening for osteoporosis-the ROSE trial.
    Osteoporos Int. 2017 Sep 5. doi: 10.1007/s00198-017-4205.
    PubMed     Text format     Abstract available


  137. CELLI M, D'Eufemia P, Persiani P, Turchetti A, et al
    Clinical and biochemical response to neridronate treatment in a patient with osteoporosis-pseudoglioma syndrome (OPPG).
    Osteoporos Int. 2017 Sep 2. doi: 10.1007/s00198-017-4214.
    PubMed     Text format     Abstract available


    August 2017
  138. LITWIC AE, Compston JE, Wyman A, Siris ES, et al
    Self-perception of fracture risk: what can it tell us?
    Osteoporos Int. 2017 Aug 31. doi: 10.1007/s00198-017-4200.
    PubMed     Text format     Abstract available


  139. LIU YY, Xue FS, Li HX
    Assessing impact of body mass index on risk of acute kidney injury and mortality in elderly patients undergoing hip fracture surgery.
    Osteoporos Int. 2017 Aug 28. doi: 10.1007/s00198-017-4194.
    PubMed     Text format    


  140. MALGO F, Hamdy NAT, Ticheler CHJM, Smit F, et al
    Value and potential limitations of vertebral fracture assessment (VFA) compared to conventional spine radiography: experience from a fracture liaison service (FLS) and a meta-analysis.
    Osteoporos Int. 2017 Aug 25. doi: 10.1007/s00198-017-4137.
    PubMed     Text format     Abstract available


  141. LIU FL, Lin CS, Yeh CC, Shih CC, et al
    Risk and outcomes of fracture in peripheral arterial disease patients: two nationwide cohort studies.
    Osteoporos Int. 2017 Aug 18. doi: 10.1007/s00198-017-4192.
    PubMed     Text format     Abstract available


  142. LIU GY, Cao GL, Tian FM, Song HP, et al
    Parathyroid hormone (1-34) promotes fracture healing in ovariectomized rats with type 2 diabetes mellitus.
    Osteoporos Int. 2017 Aug 14. doi: 10.1007/s00198-017-4148.
    PubMed     Text format     Abstract available


  143. JIA P, Bao L, Chen H, Yuan J, et al
    Risk of low-energy fracture in type 2 diabetes patients: a meta-analysis of observational studies.
    Osteoporos Int. 2017 Aug 9. doi: 10.1007/s00198-017-4183.
    PubMed     Text format     Abstract available


  144. KANIS JA, Cooper C, Rizzoli R, Abrahamsen B, et al
    Erratum to: Identification and management of patients at increased risk of osteoporotic fracture: outcomes of an ESCEO expert consensus meeting.
    Osteoporos Int. 2017 Aug 7. doi: 10.1007/s00198-017-4161.
    PubMed     Text format    


  145. JOHANSSON H, Azizieh F, Al Ali N, Alessa T, et al
    FRAX- vs. T-score-based intervention thresholds for osteoporosis.
    Osteoporos Int. 2017 Aug 7. doi: 10.1007/s00198-017-4160.
    PubMed     Text format     Abstract available


  146. ZHAO Y, Wang J, Yao W, Cai Q, et al
    Interventions for humeral shaft fractures: mixed treatment comparisons of clinical trials.
    Osteoporos Int. 2017 Aug 5. doi: 10.1007/s00198-017-4174.
    PubMed     Text format     Abstract available


  147. SCHNEIDER PS, Wall M, Brown JP, Cheung AM, et al
    Atypical femur fractures: a survey of current practices in orthopedic surgery.
    Osteoporos Int. 2017 Aug 2. doi: 10.1007/s00198-017-4155.
    PubMed     Text format     Abstract available


  148. SAITO T, Sterbenz JM, Malay S, Zhong L, et al
    Effectiveness of anti-osteoporotic drugs to prevent secondary fragility fractures: systematic review and meta-analysis.
    Osteoporos Int. 2017 Aug 2. doi: 10.1007/s00198-017-4175.
    PubMed     Text format     Abstract available


    July 2017
  149. WILLIAMS ST, Lawrence PT, Miller KL, Crook JL, et al
    A comparison of electronic and manual fracture risk assessment tools in screening elderly male US veterans at risk for osteoporosis.
    Osteoporos Int. 2017 Jul 30. doi: 10.1007/s00198-017-4172.
    PubMed     Text format     Abstract available


  150. KOH JH, Myong JP, Yoo J, Lim YW, et al
    Predisposing factors associated with atypical femur fracture among postmenopausal Korean women receiving bisphosphonate therapy: 8 years' experience in a single center.
    Osteoporos Int. 2017 Jul 27. doi: 10.1007/s00198-017-4169.
    PubMed     Text format     Abstract available


  151. WILLIAMSON S, Landeiro F, McConnell T, Fulford-Smith L, et al
    Costs of fragility hip fractures globally: a systematic review and meta-regression analysis.
    Osteoporos Int. 2017 Jul 26. doi: 10.1007/s00198-017-4153.
    PubMed     Text format     Abstract available


  152. VAN DER VELDE RY, Bours SPG, Wyers CE, Lems WF, et al
    Effect of implementation of guidelines on assessment and diagnosis of vertebral fractures in patients older than 50 years with a recent non-vertebral fracture.
    Osteoporos Int. 2017 Jul 26. doi: 10.1007/s00198-017-4147.
    PubMed     Text format     Abstract available


  153. KAMPE AJ, Costantini A, Makitie RE, Jantti N, et al
    PLS3 sequencing in childhood-onset primary osteoporosis identifies two novel disease-causing variants.
    Osteoporos Int. 2017 Jul 26. doi: 10.1007/s00198-017-4150.
    PubMed     Text format     Abstract available


  154. MCCLUNG MR, Lippuner K, Brandi ML, Zanchetta JR, et al
    Effect of denosumab on trabecular bone score in postmenopausal women with osteoporosis.
    Osteoporos Int. 2017 Jul 26. doi: 10.1007/s00198-017-4140.
    PubMed     Text format     Abstract available


  155. MARTINEZ-LAGUNA D, Nogues X, Abrahamsen B, Reyes C, et al
    Excess of all-cause mortality after a fracture in type 2 diabetic patients: a population-based cohort study.
    Osteoporos Int. 2017 Jul 25. doi: 10.1007/s00198-017-4096.
    PubMed     Text format     Abstract available


  156. NASIRI SARVI M, Luo Y
    Sideways fall-induced impact force and its effect on hip fracture risk: a review.
    Osteoporos Int. 2017 Jul 20. doi: 10.1007/s00198-017-4138.
    PubMed     Text format     Abstract available


  157. DRIESSEN JHM, Knapen LM, Geusens PPMM, van den Bergh JPW, et al
    Fracture risk reduction with use of dipeptidyl peptidase-4 inhibitors: is there immortal time bias?
    Osteoporos Int. 2017 Jul 13. doi: 10.1007/s00198-017-4120.
    PubMed     Text format    


  158. KOSTEV K, Dombrowski S
    Fracture risk reduction with use of dipeptidyl peptidase-4 inhibitors: response to Driessen et al.
    Osteoporos Int. 2017 Jul 13. doi: 10.1007/s00198-017-4139.
    PubMed     Text format    


  159. LI X, Gong X, Jiang W
    Abdominal obesity and risk of hip fracture: a meta-analysis of prospective studies.
    Osteoporos Int. 2017 Jul 12. doi: 10.1007/s00198-017-4142.
    PubMed     Text format     Abstract available


  160. COSMAN F
    Spine fracture prevalence in a nationally representative sample of US women and men aged >/=40 years: results from the National Health and Nutrition Examination Survey (NHANES) 2013-2014---supplementary presentation.
    Osteoporos Int. 2017 Jul 10. doi: 10.1007/s00198-017-3999.
    PubMed     Text format     Abstract available


  161. HANUSCH BC, Tuck SP, McNally RJQ, Wu JJ, et al
    Does regional loss of bone density explain low trauma distal forearm fractures in men (the Mr F study)?
    Osteoporos Int. 2017 Jul 6. doi: 10.1007/s00198-017-4122.
    PubMed     Text format     Abstract available


  162. XUE F, Goli V, Petraro P, McMullan T, et al
    Marginal structural model to evaluate the association between cumulative osteoporosis medication and infection using claims data.
    Osteoporos Int. 2017 Jul 6. doi: 10.1007/s00198-017-4129.
    PubMed     Text format     Abstract available


    June 2017
  163. MENDIS AS, Ganda K, Seibel MJ
    Barriers to secondary fracture prevention in primary care.
    Osteoporos Int. 2017 Jun 29. doi: 10.1007/s00198-017-4131.
    PubMed     Text format     Abstract available


  164. FISCHER S, Kapinos KA, Mulcahy A, Pinto L, et al
    Estimating the long-term functional burden of osteoporosis-related fractures.
    Osteoporos Int. 2017 Jun 24. doi: 10.1007/s00198-017-4110.
    PubMed     Text format     Abstract available


  165. LOGAN S, Thu WPP, Lay WK, Wang LY, et al
    Chronic joint pain and handgrip strength correlates with osteoporosis in mid-life women: a Singaporean cohort.
    Osteoporos Int. 2017 Jun 24. doi: 10.1007/s00198-017-4095.
    PubMed     Text format     Abstract available


  166. OSHAGBEMI OA, Driessen JHM, Pieffers A, Wouters EFM, et al
    Use of systemic glucocorticoids and the risk of major osteoporotic fractures in patients with sarcoidosis.
    Osteoporos Int. 2017 Jun 21. doi: 10.1007/s00198-017-4115.
    PubMed     Text format     Abstract available


  167. LEE YK, Kim TY, Ha YC, Song SH, et al
    Atypical subtrochanteric fractures in Korean hip fracture study.
    Osteoporos Int. 2017 Jun 14. doi: 10.1007/s00198-017-4112.
    PubMed     Text format     Abstract available


  168. LESLIE WD, Majumdar SR, Morin SN, Lix LM, et al
    FRAX for fracture prediction shorter and longer than 10 years: the Manitoba BMD registry.
    Osteoporos Int. 2017 Jun 7. doi: 10.1007/s00198-017-4091.
    PubMed     Text format     Abstract available


  169. WEYCKER D, Edelsberg J, Barron R, Atwood M, et al
    Predictors of near-term fracture in osteoporotic women aged >/=65 years, based on data from the study of osteoporotic fractures.
    Osteoporos Int. 2017 Jun 7. doi: 10.1007/s00198-017-4103.
    PubMed     Text format     Abstract available


  170. LEHMANN T, Aeberli D
    Possible protective effect of switching from denosumab to zoledronic acid on vertebral fractures.
    Osteoporos Int. 2017 Jun 6. doi: 10.1007/s00198-017-4108.
    PubMed     Text format    


  171. SVENSSON HK, Olsson L-, Hansson T, Karlsson J, et al
    The effects of person-centered or other supportive interventions in older women with osteoporotic vertebral compression fractures-a systematic review of the literature.
    Osteoporos Int. 2017 Jun 6. doi: 10.1007/s00198-017-4099.
    PubMed     Text format     Abstract available


  172. SHAH VN, Harrall KK, Shah CS, Gallo TL, et al
    Bone mineral density at femoral neck and lumbar spine in adults with type 1 diabetes: a meta-analysis and review of the literature.
    Osteoporos Int. 2017 Jun 3. doi: 10.1007/s00198-017-4097.
    PubMed     Text format     Abstract available


  173. SAHNI S, Soedamah-Muthu SS, Weaver CM
    Higher milk intake increases fracture risk: confounding or true association?
    Osteoporos Int. 2017 Jun 1. doi: 10.1007/s00198-017-4088.
    PubMed     Text format    


    May 2017
  174. CUI L, Chen L, Xia W, Jiang Y, et al
    Vertebral fracture in postmenopausal Chinese women: a population-based study.
    Osteoporos Int. 2017 May 30. doi: 10.1007/s00198-017-4085.
    PubMed     Text format     Abstract available


  175. DONZELLI A, Battaggia A, Schivalocchi A
    Statin use does not protect from fractures: the healthy adherer effect is a plausible explanation in observational studies.
    Osteoporos Int. 2017 May 29. doi: 10.1007/s00198-017-4069.
    PubMed     Text format    


  176. WRIGHT NC, Foster PJ, Mudano AS, Melnick JA, et al
    Assessing the feasibility of the Effectiveness of Discontinuing Bisphosphonates trial: a pilot study.
    Osteoporos Int. 2017 May 24. doi: 10.1007/s00198-017-4073.
    PubMed     Text format     Abstract available


  177. KESHISHIAN A, Boytsov N, Burge R, Krohn K, et al
    Examining the treatment gap and risk of subsequent fractures among females with a fragility fracture in the US Medicare population.
    Osteoporos Int. 2017 May 23. doi: 10.1007/s00198-017-4072.
    PubMed     Text format     Abstract available


  178. FRAENKEL M, Yitshak-Sade M, Beacher L, Carmeli M, et al
    Is the association between hip fractures and seasonality modified by influenza vaccination? An ecological study.
    Osteoporos Int. 2017 May 23. doi: 10.1007/s00198-017-4077.
    PubMed     Text format     Abstract available


  179. VALA CH, Sundh V, Mellstrom D
    Increased risk of hip fracture among spouses-evidence of a homogamy effect: response to comments by Minkov.
    Osteoporos Int. 2017 May 22. doi: 10.1007/s00198-017-4092.
    PubMed     Text format    


  180. MINKOV D
    Hip fractures or femoral fractures?
    Osteoporos Int. 2017 May 22. doi: 10.1007/s00198-017-3942.
    PubMed     Text format    


  181. ABDERHALDEN L, Weaver FM, Bethel M, Demirtas H, et al
    Response to Sabour: Dual-energy X-ray absorptiometry and fracture prediction in patients with spinal cord injuries and disorders: methodological issues.
    Osteoporos Int. 2017 May 15. doi: 10.1007/s00198-017-4056.
    PubMed     Text format    


  182. SABOUR S
    Dual-energy X-ray absorptiometry and fracture prediction in patients with spinal cord injuries and disorders: methodological issues.
    Osteoporos Int. 2017 May 13. doi: 10.1007/s00198-017-3990.
    PubMed     Text format    


  183. GULIN T, Kruljac I, Kirigin Bilos LS, Gulin M, et al
    The role of adipokines as prognostic factors of one-year mortality in hip fracture patients.
    Osteoporos Int. 2017 May 13. doi: 10.1007/s00198-017-4068.
    PubMed     Text format     Abstract available


  184. PEREZ-SAEZ MJ, Herrera S, Prieto-Alhambra D, Vilaplana L, et al
    Bone density, microarchitecture, and material strength in chronic kidney disease patients at the time of kidney transplantation.
    Osteoporos Int. 2017 May 11. doi: 10.1007/s00198-017-4065.
    PubMed     Text format     Abstract available


  185. YIN P, Lv H, Li Y, Meng Y, et al
    The association between serum uric acid level and the risk of fractures: a systematic review and meta-analysis.
    Osteoporos Int. 2017 May 9. doi: 10.1007/s00198-017-4059.
    PubMed     Text format     Abstract available


  186. LIN YC, Huang TS, Wu JS, Cheung YC, et al
    Are bilateral decubitus views necessary in assessing for vertebral compression fractures using DXA vertebral fracture assessment?
    Osteoporos Int. 2017 May 9. doi: 10.1007/s00198-017-4040.
    PubMed     Text format     Abstract available


  187. BOGL HP, Aspenberg P, Schilcher J
    Undisturbed local bone formation capacity in patients with atypical femoral fractures: a case series.
    Osteoporos Int. 2017 May 4. doi: 10.1007/s00198-017-4058.
    PubMed     Text format     Abstract available


  188. MALGO F, Hamdy NAT, Papapoulos SE, Appelman-Dijkstra NM, et al
    Bone material strength index as measured by impact microindentation is low in patients with fractures irrespective of fracture site.
    Osteoporos Int. 2017 May 2. doi: 10.1007/s00198-017-4054.
    PubMed     Text format     Abstract available


  189. MCCLUNG MR, Wagman RB, Miller PD, Wang A, et al
    Observations following discontinuation of long-term denosumab therapy.
    Osteoporos Int. 2017;28:1723-1732.
    PubMed     Text format     Abstract available


    April 2017
  190. DOMBROWSKI S, Kostev K, Jacob L
    Use of dipeptidyl peptidase-4 inhibitors and risk of bone fracture in patients with type 2 diabetes in Germany-A retrospective analysis of real-world data.
    Osteoporos Int. 2017 Apr 29. doi: 10.1007/s00198-017-4051.
    PubMed     Text format     Abstract available


  191. KANIS JA, Cooper C, Rizzoli R, Abrahamsen B, et al
    Identification and management of patients at increased risk of osteoporotic fracture: outcomes of an ESCEO expert consensus meeting.
    Osteoporos Int. 2017 Apr 27. doi: 10.1007/s00198-017-4009.
    PubMed     Text format     Abstract available


  192. MCCLOSKEY EV
    Identification of vertebral fractures: a moderately severe solution?
    Osteoporos Int. 2017 Apr 27. doi: 10.1007/s00198-017-4042.
    PubMed     Text format    


  193. BERRY SD, Zullo AR, McConeghy K, Lee Y, et al
    Defining hip fracture with claims data: outpatient and provider claims matter.
    Osteoporos Int. 2017 Apr 26. doi: 10.1007/s00198-017-4008.
    PubMed     Text format     Abstract available


  194. LI C, Zeng Y, Tao L, Liu S, et al
    Meta-analysis of hypertension and osteoporotic fracture risk in women and men.
    Osteoporos Int. 2017 Apr 26. doi: 10.1007/s00198-017-4050.
    PubMed     Text format     Abstract available


  195. CLARK EM, Cummings SR, Schousboe JT
    Spinal radiographs in those with back pain-when are they appropriate to diagnose vertebral fractures?
    Osteoporos Int. 2017 Apr 25. doi: 10.1007/s00198-017-4052.
    PubMed     Text format     Abstract available


  196. MOBERG L, Nilsson PM, Samsioe G, Sallsten G, et al
    Increased blood cadmium levels were not associated with increased fracture risk but with increased total mortality in women: the Malmo Diet and Cancer Study.
    Osteoporos Int. 2017 Apr 21. doi: 10.1007/s00198-017-4047.
    PubMed     Text format     Abstract available


  197. DOMBROWSKI S, Jacob L, Hadji P, Kostev K, et al
    Oral contraceptive use and fracture risk-a retrospective study of 12,970 women in the UK.
    Osteoporos Int. 2017 Apr 13. doi: 10.1007/s00198-017-4036.
    PubMed     Text format     Abstract available


  198. SATO H, Kondo N, Nakatsue T, Wada Y, et al
    High and pointed type of femoral localized reaction frequently extends to complete and incomplete atypical femoral fracture in patients with autoimmune diseases on long-term glucocorticoids and bisphosphonates.
    Osteoporos Int. 2017 Apr 13. doi: 10.1007/s00198-017-4038.
    PubMed     Text format     Abstract available


  199. YAN J, Liu HJ, Li H, Chen L, et al
    Circulating periostin levels increase in association with bone density loss and healing progression during the early phase of hip fracture in Chinese older women.
    Osteoporos Int. 2017 Apr 5. doi: 10.1007/s00198-017-4034.
    PubMed     Text format     Abstract available


  200. BARDAI G, Ward LM, Trejo P, Moffatt P, et al
    Molecular diagnosis in children with fractures but no extraskeletal signs of osteogenesis imperfecta.
    Osteoporos Int. 2017 Apr 4. doi: 10.1007/s00198-017-4031.
    PubMed     Text format     Abstract available


  201. HUNG YC, Lin CC, Chen HJ, Chang MP, et al
    Severe hypoglycemia and hip fracture in patients with type 2 diabetes: a nationwide population-based cohort study.
    Osteoporos Int. 2017 Apr 3. doi: 10.1007/s00198-017-4021.
    PubMed     Text format     Abstract available


    March 2017
  202. PETIT M-, Bryere J, Maravic M, Pallaro F, et al
    Hip fracture incidence and social deprivation: results from a French ecological study.
    Osteoporos Int. 2017 Mar 23. doi: 10.1007/s00198-017-3998.
    PubMed     Text format     Abstract available


  203. CHEN YY, Feng JY, Ting WY, Yen YF, et al
    Increased risk of incident osteoporosis and osteoporotic fracture in tuberculosis patients: a population-based study in a tuberculosis-endemic area.
    Osteoporos Int. 2017 Mar 22. doi: 10.1007/s00198-017-3939.
    PubMed     Text format     Abstract available


  204. LAINE CM, Landin-Wilhelmsen K
    Case report: fast reversal of severe osteoporosis after correction of excessive levothyroxine treatment and long-term follow-up.
    Osteoporos Int. 2017 Mar 21. doi: 10.1007/s00198-017-3981.
    PubMed     Text format     Abstract available


  205. THOMPSON MJ, Aitken DA, Otahal P, Cicolini J, et al
    The relationship between cumulative lifetime ultraviolet radiation exposure, bone mineral density, falls risk and fractures in older adults.
    Osteoporos Int. 2017 Mar 20. doi: 10.1007/s00198-017-4001.
    PubMed     Text format     Abstract available


  206. MOHD-TAHIR NA, Li SC
    Economic burden of osteoporosis-related hip fracture in Asia: a systematic review.
    Osteoporos Int. 2017 Mar 17. doi: 10.1007/s00198-017-3985.
    PubMed     Text format     Abstract available


  207. ASADIPOOYA K, Graves L, Greene LW
    Transient osteoporosis of the hip: review of the literature.
    Osteoporos Int. 2017 Mar 17. doi: 10.1007/s00198-017-3952.
    PubMed     Text format     Abstract available


  208. MAHARLOUEI N, Atefi S, Namazi H, Kazemifar S, et al
    The incidence of hip fracture in Shiraz, Iran: a promising rate comparing to previous studies.
    Osteoporos Int. 2017 Mar 16. doi: 10.1007/s00198-017-3983.
    PubMed     Text format     Abstract available


  209. MAJUMDAR SR, Lier DA, Hanley DA, Juby AG, et al
    Economic evaluation of a population-based osteoporosis intervention for outpatients with non-traumatic non-hip fractures: the "Catch a Break" 1i [type C] FLS.
    Osteoporos Int. 2017 Mar 9. doi: 10.1007/s00198-017-3986.
    PubMed     Text format     Abstract available


  210. IMAI T, Tanaka S, Kawakami K, Miyazaki T, et al
    Health state utility values and patient-reported outcomes before and after vertebral and non-vertebral fractures in an osteoporosis clinical trial.
    Osteoporos Int. 2017 Mar 6. doi: 10.1007/s00198-017-3966.
    PubMed     Text format     Abstract available


  211. KERR C, Bottomley C, Shingler S, Giangregorio L, et al
    The importance of physical function to people with osteoporosis.
    Osteoporos Int. 2017 Mar 6. doi: 10.1007/s00198-017-3911.
    PubMed     Text format     Abstract available


  212. MORIWAKI K, Mouri M, Hagino H
    Cost-effectiveness analysis of once-yearly injection of zoledronic acid for the treatment of osteoporosis in Japan.
    Osteoporos Int. 2017 Mar 6. doi: 10.1007/s00198-017-3973.
    PubMed     Text format     Abstract available


  213. WEI Y, Tian W, Zhang GL, Lv YW, et al
    Thoracolumbar kyphosis is associated with compressive vertebral fracture in postmenopausal women.
    Osteoporos Int. 2017 Mar 1. doi: 10.1007/s00198-017-3971.
    PubMed     Text format     Abstract available


    February 2017
  214. MERLE B, Chapurlat R, Vignot E, Thomas T, et al
    Post-fracture care: do we need to educate patients rather than doctors? The PREVOST randomized controlled trial.
    Osteoporos Int. 2017 Feb 28. doi: 10.1007/s00198-017-3953.
    PubMed     Text format     Abstract available


  215. NARDONE V, Tini P, Carbone SF, Grassi A, et al
    Bone texture analysis using CT-simulation scans to individuate risk parameters for radiation-induced insufficiency fractures.
    Osteoporos Int. 2017 Feb 27. doi: 10.1007/s00198-017-3968.
    PubMed     Text format     Abstract available


  216. TAMAKI J, Iki M, Sato Y, Kajita E, et al
    Total 25-hydroxyvitamin D levels predict fracture risk: results from the 15-year follow-up of the Japanese Population-based Osteoporosis (JPOS) Cohort Study.
    Osteoporos Int. 2017 Feb 27. doi: 10.1007/s00198-017-3967.
    PubMed     Text format     Abstract available


  217. ROUX C, Briot K
    Imminent fracture risk.
    Osteoporos Int. 2017 Feb 24. doi: 10.1007/s00198-017-3976.
    PubMed     Text format     Abstract available


  218. MORFELD JC, Vennedey V, Muller D, Pieper D, et al
    Patient education in osteoporosis prevention: a systematic review focusing on methodological quality of randomised controlled trials.
    Osteoporos Int. 2017 Feb 24. doi: 10.1007/s00198-017-3946.
    PubMed     Text format     Abstract available


  219. LEE SH, Hsu WT, Lai CC, Esmaily-Fard A, et al
    Erratum to: Use of antipsychotics increases the risk of fracture: a systematic review and meta-analysis.
    Osteoporos Int. 2017 Feb 23. doi: 10.1007/s00198-017-3938.
    PubMed     Text format    


  220. FENG Y, Cheng G, Wang H, Chen B, et al
    The associations between serum 25-hydroxyvitamin D level and the risk of total fracture and hip fracture.
    Osteoporos Int. 2017 Feb 20. doi: 10.1007/s00198-017-3955.
    PubMed     Text format     Abstract available


  221. MORI T, Crandall CJ, Ganz DA
    Cost-effectiveness of denosumab versus oral alendronate for elderly osteoporotic women in Japan.
    Osteoporos Int. 2017 Feb 17. doi: 10.1007/s00198-017-3940.
    PubMed     Text format     Abstract available


  222. UNGPRASERT P, Crowson CS, Matteson EL
    Risk of fragility fracture among patients with sarcoidosis: a population-based study 1976-2013.
    Osteoporos Int. 2017 Feb 16. doi: 10.1007/s00198-017-3962.
    PubMed     Text format     Abstract available


  223. DEDE AD, Trovas G, Chronopoulos E, Triantafyllopoulos IK, et al
    Response to: A role for thiazide diuretic therapy in preventing bone loss, fracture and nephrolithiasis in individuals with thalassemia and hypercalciuria?
    Osteoporos Int. 2017 Feb 13. doi: 10.1007/s00198-017-3927.
    PubMed     Text format    


  224. MORTON A
    A role for thiazide diuretic therapy in preventing bone loss, fracture, and nephrolithiasis in individuals with thalassemia and hypercalciuria?
    Osteoporos Int. 2017 Feb 13. doi: 10.1007/s00198-017-3922.
    PubMed     Text format    


  225. COSMAN F, Krege JH, Looker AC, Schousboe JT, et al
    Spine fracture prevalence in a nationally representative sample of US women and men aged >/=40 years: results from the National Health and Nutrition Examination Survey (NHANES) 2013-2014.
    Osteoporos Int. 2017 Feb 7. doi: 10.1007/s00198-017-3948.
    PubMed     Text format     Abstract available


  226. HARVEY NC, McCloskey EV, Mitchell PJ, Dawson-Hughes B, et al
    Mind the (treatment) gap: a global perspective on current and future strategies for prevention of fragility fractures.
    Osteoporos Int. 2017 Feb 7. doi: 10.1007/s00198-016-3894.
    PubMed     Text format     Abstract available


  227. BALLANE G, Cauley JA, Luckey MM, El-Hajj Fuleihan G, et al
    Worldwide prevalence and incidence of osteoporotic vertebral fractures.
    Osteoporos Int. 2017 Feb 6. doi: 10.1007/s00198-017-3909.
    PubMed     Text format     Abstract available


  228. LESPESSAILLES E, Cortet B, Legrand E, Guggenbuhl P, et al
    Low-trauma fractures without osteoporosis.
    Osteoporos Int. 2017 Feb 4. doi: 10.1007/s00198-017-3921.
    PubMed     Text format     Abstract available


  229. PADRON-MONEDERO A, Lopez-Cuadrado T, Galan I, Martinez-Sanchez EV, et al
    Effect of comorbidities on the association between age and hospital mortality after fall-related hip fracture in elderly patients.
    Osteoporos Int. 2017 Feb 3. doi: 10.1007/s00198-017-3926.
    PubMed     Text format     Abstract available


  230. MIKULA AL, Hetzel SJ, Binkley N, Anderson PA, et al
    Validity of height loss as a predictor for prevalent vertebral fractures, low bone mineral density, and vitamin D deficiency.
    Osteoporos Int. 2017 Feb 3. doi: 10.1007/s00198-017-3937.
    PubMed     Text format     Abstract available


  231. CARBONE LD, Buzkova P, Fink HA, Robbins JA, et al
    Association of DPP-4 activity with BMD, body composition, and incident hip fracture: the Cardiovascular Health Study.
    Osteoporos Int. 2017 Feb 2. doi: 10.1007/s00198-017-3916.
    PubMed     Text format     Abstract available


  232. LANDI F, Calvani R, Ortolani E, Salini S, et al
    The association between sarcopenia and functional outcomes among older patients with hip fracture undergoing in-hospital rehabilitation.
    Osteoporos Int. 2017 Feb 2. doi: 10.1007/s00198-017-3929.
    PubMed     Text format     Abstract available


    January 2017
  233. MUSCHITZ C, Kocijan R, Baierl A, Dormann R, et al
    Preceding and subsequent high- and low-trauma fracture patterns-a 13-year epidemiological study in females and males in Austria.
    Osteoporos Int. 2017 Jan 30. doi: 10.1007/s00198-017-3925.
    PubMed     Text format     Abstract available


  234. LEE SH, Hsu WT, Lai CC, Amin EF, et al
    Use of antipsychotics increases the risk of fracture: a systematic review and meta-analysis.
    Osteoporos Int. 2017 Jan 12. doi: 10.1007/s00198-016-3881.
    PubMed     Text format     Abstract available


  235. BROZEK W, Reichardt B, Zwerina J, Dimai HP, et al
    Use of proton pump inhibitors and mortality after hip fracture in a nationwide study.
    Osteoporos Int. 2017 Jan 12. doi: 10.1007/s00198-017-3910.
    PubMed     Text format     Abstract available


  236. AYUS JC, Bellido T, Negri AL
    Hyponatremia and fractures: should hyponatremia be further studied as a potential biochemical risk factor to be included in FRAX algorithms?
    Osteoporos Int. 2017 Jan 10. doi: 10.1007/s00198-017-3907.
    PubMed     Text format     Abstract available


  237. FUNG TT, Meyer HE, Willett WC, Feskanich D, et al
    Protein intake and risk of hip fractures in postmenopausal women and men age 50 and older.
    Osteoporos Int. 2017 Jan 10. doi: 10.1007/s00198-016-3898.
    PubMed     Text format     Abstract available


  238. HADJI P, Boekhoff J, Hahn M, Hellmeyer L, et al
    Pregnancy-associated osteoporosis: a case-control study.
    Osteoporos Int. 2017 Jan 10. doi: 10.1007/s00198-016-3897.
    PubMed     Text format     Abstract available


    December 2016
  239. BURGE RT, Disch DP, Gelwicks S, Zhang X, et al
    Hip and other fragility fracture incidence in real-world teriparatide-treated patients in the United States.
    Osteoporos Int. 2016 Dec 27. doi: 10.1007/s00198-016-3888.
    PubMed     Text format     Abstract available


  240. JOHANSSON H, Siggeirsdottir K, Harvey NC, Oden A, et al
    Imminent risk of fracture after fracture.
    Osteoporos Int. 2016 Dec 27. doi: 10.1007/s00198-016-3868.
    PubMed     Text format     Abstract available


  241. ROGERS TS, Blackwell TL, Lane NE, Tranah G, et al
    Rest-activity patterns and falls and fractures in older men.
    Osteoporos Int. 2016 Dec 24. doi: 10.1007/s00198-016-3874.
    PubMed     Text format     Abstract available


  242. BARRO V, Nunez JH, Gargallo-Margarit A, Sallent A, et al
    Bilateral insufficiency hip fractures after bariatric surgery.
    Osteoporos Int. 2016 Dec 23. doi: 10.1007/s00198-016-3889.
    PubMed     Text format     Abstract available


  243. FAHRLEITNER-PAMMER A, Wagner D, Krisper P, Amrein K, et al
    Teriparatide treatment in a heart transplant patient with a chronic kidney disease and a low-turnover bone disease: a case report.
    Osteoporos Int. 2016.
    PubMed     Text format     Abstract available


  244. MANA DL, Zanchetta MB, Zanchetta JR
    Retreatment with teriparatide: our experience in three patients with severe secondary osteoporosis.
    Osteoporos Int. 2016.
    PubMed     Text format     Abstract available


  245. WRIGHT NC, Saag KG, Dawson-Hughes B, Khosla S, et al
    The impact of the new National Bone Health Alliance (NBHA) diagnostic criteria on the prevalence of osteoporosis in the USA.
    Osteoporos Int. 2016.
    PubMed     Text format     Abstract available


  246. FECHTENBAUM J, Kolta S, Briot K, Roux C, et al
    Vertebral fracture assessment by dual X-ray absorptiometry.
    Osteoporos Int. 2016.
    PubMed     Text format    


  247. RUD B, Hyldstrup L
    Vertebral fracture assessment by dual X-ray absorptiometry: reply to comments by Fechtenbaum et al.
    Osteoporos Int. 2016.
    PubMed     Text format    


  248. ABDERHALDEN L, Weaver FM, Bethel M, Demirtas H, et al
    Dual-energy X-ray absorptiometry and fracture prediction in patients with spinal cord injuries and disorders.
    Osteoporos Int. 2016.
    PubMed     Text format     Abstract available


  249. CIRNIGLIARO CM, Myslinski MJ, La Fountaine MF, Kirshblum SC, et al
    Bone loss at the distal femur and proximal tibia in persons with spinal cord injury: imaging approaches, risk of fracture, and potential treatment options.
    Osteoporos Int. 2016.
    PubMed     Text format     Abstract available


  250. KRISTENSEN PK, Thillemann TM, Pedersen AB, Soballe K, et al
    Socioeconomic inequality in clinical outcome among hip fracture patients: a nationwide cohort study.
    Osteoporos Int. 2016.
    PubMed     Text format     Abstract available


    November 2016
  251. MAWATARI T, Muraoka R, Iwamoto Y
    Relationship between baseline characteristics and response to risedronate treatment for osteoporosis: data from three Japanese phase III trials.
    Osteoporos Int. 2016.
    PubMed     Text format     Abstract available


  252. LAU TW, Fang C, Leung F
    The effectiveness of a multidisciplinary hip fracture care model in improving the clinical outcome and the average cost of manpower.
    Osteoporos Int. 2016.
    PubMed     Text format     Abstract available


  253. AN T, Hao J, Sun S, Li R, et al
    Efficacy of statins for osteoporosis: a systematic review and meta-analysis.
    Osteoporos Int. 2016.
    PubMed     Text format     Abstract available


  254. JACOB L, Kostev K
    Impact of attention deficit hyperactivity disorder therapy on fracture risk in children treated in German pediatric practices.
    Osteoporos Int. 2016.
    PubMed     Text format     Abstract available


  255. SAEZ-LOPEZ P, Branas F, Sanchez-Hernandez N, Alonso-Garcia N, et al
    Hip fracture registries: utility, description, and comparison.
    Osteoporos Int. 2016.
    PubMed     Text format     Abstract available


  256. SANCHEZ A, Blanco R
    Osteonecrosis of the jaw (ONJ) and atypical femoral fracture (AFF) in an osteoporotic patient chronically treated with bisphosphonates.
    Osteoporos Int. 2016.
    PubMed     Text format     Abstract available


  257. KIM H, Baek KH, Lee SY, Ahn SH, et al
    Association of circulating dipeptidyl-peptidase 4 levels with osteoporotic fracture in postmenopausal women.
    Osteoporos Int. 2016.
    PubMed     Text format     Abstract available


  258. PEDERSEN AB, Gammelager H, Kahlert J, Sorensen HT, et al
    Impact of body mass index on risk of acute kidney injury and mortality in elderly patients undergoing hip fracture surgery.
    Osteoporos Int. 2016.
    PubMed     Text format     Abstract available


  259. WU TY, Hu HY, Lin SY, Chie WC, et al
    Trends in hip fracture rates in Taiwan: a nationwide study from 1996 to 2010.
    Osteoporos Int. 2016.
    PubMed     Text format     Abstract available


  260. KRUSE C, Eiken P, Vestergaard P
    Clinical fracture risk evaluated by hierarchical agglomerative clustering.
    Osteoporos Int. 2016.
    PubMed     Text format     Abstract available


  261. RAY R, Clement ND, Aitken SA, McQueen MM, et al
    High mortality in younger patients with major osteoporotic fractures.
    Osteoporos Int. 2016.
    PubMed     Text format     Abstract available


  262. CHEN FP, Shyu YC, Fu TS, Sun CC, et al
    Secular trends in incidence and recurrence rates of hip fracture: a nationwide population-based study.
    Osteoporos Int. 2016.
    PubMed     Text format     Abstract available


  263. MATHAVAN N, Tagil M, Isaksson H
    Do osteoporotic fractures constitute a greater recalcitrant challenge for skeletal regeneration? Investigating the efficacy of BMP-7 and zoledronate treatment of diaphyseal fractures in an open fracture osteoporotic rat model.
    Osteoporos Int. 2016.
    PubMed     Text format     Abstract available


  264. SHAH A, Prieto-Alhambra D, Hawley S, Delmestri A, et al
    Geographic variation in secondary fracture prevention after a hip fracture during 1999-2013: a UK study.
    Osteoporos Int. 2016.
    PubMed     Text format     Abstract available


    October 2016
  265. ZERBINI CA, Clark P, Mendez-Sanchez L, Pereira RM, et al
    Biologic therapies and bone loss in rheumatoid arthritis.
    Osteoporos Int. 2016.
    PubMed     Text format     Abstract available


  266. SUMREIN BO, Huttunen TT, Launonen AP, Berg HE, et al
    Proximal humeral fractures in Sweden-a registry-based study.
    Osteoporos Int. 2016.
    PubMed     Text format     Abstract available


  267. MA J, McMillan HJ, Karaguzel G, Goodin C, et al
    The time to and determinants of first fractures in boys with Duchenne muscular dystrophy.
    Osteoporos Int. 2016.
    PubMed     Text format     Abstract available


  268. ADAMS AL, Xue F, Chantra JQ, Dell RM, et al
    Sensitivity and specificity of radiographic characteristics in atypical femoral fractures.
    Osteoporos Int. 2016.
    PubMed     Text format     Abstract available


  269. BEATON DE, Vidmar M, Pitzul KB, Sujic R, et al
    Addition of a fracture risk assessment to a coordinator's role improved treatment rates within 6 months of screening in a fragility fracture screening program.
    Osteoporos Int. 2016.
    PubMed     Text format     Abstract available


  270. FINK HA, Litwack-Harrison S, Taylor BC, Bauer DC, et al
    Erratum to: Clinical utility of routine laboratory testing to identify possible secondary causes in older men with osteoporosis: the osteoporotic fractures in men (MrOS) study.
    Osteoporos Int. 2016.
    PubMed     Text format    


  271. BELHASSEN M, Confavreux CB, Cortet B, Lamezec L, et al
    Anti-osteoporotic treatments in France: initiation, persistence and switches over 6 years of follow-up.
    Osteoporos Int. 2016.
    PubMed     Text format     Abstract available


  272. HARVEY NC, Biver E, Kaufman JM, Bauer J, et al
    The role of calcium supplementation in healthy musculoskeletal ageing : An expert consensus meeting of the European Society for Clinical and Economic Aspects of Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (ESCEO) and the International Fo
    Osteoporos Int. 2016.
    PubMed     Text format     Abstract available


  273. HILIGSMANN M, Burlet N, Fardellone P, Al-Daghri N, et al
    Public health impact and economic evaluation of vitamin D-fortified dairy products for fracture prevention in France.
    Osteoporos Int. 2016.
    PubMed     Text format     Abstract available


  274. IKI M, Fujita Y, Tamaki J, Kouda K, et al
    Incident fracture associated with increased risk of mortality even after adjusting for frailty status in elderly Japanese men: the Fujiwara-kyo Osteoporosis Risk in Men (FORMEN) Cohort Study.
    Osteoporos Int. 2016.
    PubMed     Text format     Abstract available


  275. SCHOUSBOE JT, Paudel ML, Taylor BC, Kats AM, et al
    Pre-fracture individual characteristics associated with high total health care costs after hip fracture.
    Osteoporos Int. 2016.
    PubMed     Text format     Abstract available


  276. YOSHIMURA M, Moriwaki K, Noto S, Takiguchi T, et al
    A model-based cost-effectiveness analysis of osteoporosis screening and treatment strategy for postmenopausal Japanese women.
    Osteoporos Int. 2016.
    PubMed     Text format     Abstract available


  277. MORI T, Crandall CJ, Ganz DA
    Cost-effectiveness of combined oral bisphosphonate therapy and falls prevention exercise for fracture prevention in the USA.
    Osteoporos Int. 2016.
    PubMed     Text format     Abstract available


  278. SU Y, Leung J, Hans D, Aubry-Rozier B, et al
    Added clinical use of trabecular bone score to BMD for major osteoporotic fracture prediction in older Chinese people: the Mr. OS and Ms. OS cohort study in Hong Kong.
    Osteoporos Int. 2016.
    PubMed     Text format     Abstract available


  279. KLOP C, van Staa TP, Cooper C, Harvey NC, et al
    The epidemiology of mortality after fracture in England: variation by age, sex, time, geographic location, and ethnicity.
    Osteoporos Int. 2016.
    PubMed     Text format     Abstract available


  280. WALLACE ER, Siscovick DS, Sitlani CM, Dublin S, et al
    Incident atrial fibrillation and the risk of fracture in the cardiovascular health study.
    Osteoporos Int. 2016.
    PubMed     Text format     Abstract available


  281. SOLBAKKEN SM, Meyer HE, Stigum H, Sogaard AJ, et al
    Excess mortality following hip fracture: impact of self-perceived health, smoking, and body mass index. A NOREPOS study.
    Osteoporos Int. 2016.
    PubMed     Text format     Abstract available


  282. RUGGIERO C, Bonamassa L, Pelini L, Prioletta I, et al
    Early post-surgical cognitive dysfunction is a risk factor for mortality among hip fracture hospitalized older persons.
    Osteoporos Int. 2016.
    PubMed     Text format     Abstract available


  283. KAMYCHEVA E, Goto T, Camargo CA Jr
    Celiac disease is associated with reduced bone mineral density and increased FRAX scores in the US National Health and Nutrition Examination Survey.
    Osteoporos Int. 2016.
    PubMed     Text format     Abstract available


  284. MORIWAKI K, Noto S
    Economic evaluation of osteoporosis liaison service for secondary fracture prevention in postmenopausal osteoporosis patients with previous hip fracture in Japan.
    Osteoporos Int. 2016.
    PubMed     Text format     Abstract available


    September 2016
  285. ATTERITANO M, Di Mauro E, Canale V, Bruzzese AM, et al
    Higher serum sclerostin levels and insufficiency of vitamin D are strongly associated with vertebral fractures in hemodialysis patients: a case control study.
    Osteoporos Int. 2016.
    PubMed     Text format     Abstract available


  286. CHEN J, Smerdely P
    Hypocalcaemia after denosumab in older people following fracture.
    Osteoporos Int. 2016.
    PubMed     Text format     Abstract available


  287. CHAKHTOURA M, Leslie WD, McClung M, Cheung AM, et al
    The FRAX-based Lebanese osteoporosis treatment guidelines: rationale for a hybrid model.
    Osteoporos Int. 2016.
    PubMed     Text format     Abstract available


  288. SMALLWOOD AJ, Schapira MM, Fedders M, Neuner JM, et al
    A pilot randomized controlled trial of a decision aid with tailored fracture risk tool delivered via a patient portal.
    Osteoporos Int. 2016.
    PubMed     Text format     Abstract available


  289. ROSENGREN BE, Bjork J, Cooper C, Abrahamsen B, et al
    Recent hip fracture trends in Sweden and Denmark with age-period-cohort effects.
    Osteoporos Int. 2016.
    PubMed     Text format     Abstract available


  290. AVENELL A, Bolland MJ, Grey A, Reid IR, et al
    Further major uncorrected errors in National Osteoporosis Foundation meta-analyses of calcium and vitamin D supplementation in fracture prevention.
    Osteoporos Int. 2016.
    PubMed     Text format    


  291. BALOGH R, Wood J, Dobranowski K, Lin E, et al
    Low-trauma fractures and bone mineral density testing in adults with and without intellectual and developmental disabilities: a population study.
    Osteoporos Int. 2016.
    PubMed     Text format     Abstract available


  292. NAKAMURA T, Fukunaga M, Nakano T, Kishimoto H, et al
    Efficacy and safety of once-yearly zoledronic acid in Japanese patients with primary osteoporosis: two-year results from a randomized placebo-controlled double-blind study (ZOledroNate treatment in Efficacy to osteoporosis; ZONE study).
    Osteoporos Int. 2016.
    PubMed     Text format     Abstract available


    August 2016
  293. NI W, Jiang Y
    Evaluation on the cost-effective threshold of osteoporosis treatment on elderly women in China using discrete event simulation model.
    Osteoporos Int. 2016.
    PubMed     Text format     Abstract available


  294. SILVA BC, Rubin MR, Cusano NE, Bilezikian JP, et al
    Bone imaging in hypoparathyroidism.
    Osteoporos Int. 2016.
    PubMed     Text format     Abstract available


  295. DEDE AD, Trovas G, Chronopoulos E, Triantafyllopoulos IK, et al
    Thalassemia-associated osteoporosis: a systematic review on treatment and brief overview of the disease.
    Osteoporos Int. 2016.
    PubMed     Text format     Abstract available


  296. KIM YW, Kim JH, Yoon SH, Lee JH, et al
    Vertebral bone attenuation on low-dose chest CT: quantitative volumetric analysis for bone fragility assessment.
    Osteoporos Int. 2016.
    PubMed     Text format     Abstract available


    July 2016
  297. LO JC, Kim S, Chandra M, Ettinger B, et al
    Applying ethnic-specific bone mineral density T-scores to Chinese women in the USA.
    Osteoporos Int. 2016.
    PubMed     Text format     Abstract available


    June 2016
  298. BARZILAY JI, Buzkova P, Fink HA, Cauley JA, et al
    Systemic markers of microvascular disease and bone mineral density in older adults : The cardiovascular health study.
    Osteoporos Int. 2016.
    PubMed     Text format     Abstract available


    May 2016
  299. SHIRAKI M, Ueda S, Sugimoto T, Kuroda T, et al
    Treatment responses with once-weekly teriparatide therapy for osteoporosis.
    Osteoporos Int. 2016.
    PubMed     Text format     Abstract available


  300. HOPKINS RB, Burke N, Von Keyserlingk C, Leslie WD, et al
    The current economic burden of illness of osteoporosis in Canada.
    Osteoporos Int. 2016.
    PubMed     Text format     Abstract available


  301. MCCLUNG MR
    Cancel the denosumab holiday.
    Osteoporos Int. 2016;27:1677-82.
    PubMed     Text format    


  302. PAUPITZ JA, Lima GL, Alvarenga JC, Oliveira RM, et al
    Bone impairment assessed by HR-pQCT in juvenile-onset systemic lupus erythematosus.
    Osteoporos Int. 2016;27:1839-48.
    PubMed     Text format     Abstract available


  303. YAN L, He B, Guo H, Liu T, et al
    The prospective self-controlled study of unilateral transverse process-pedicle and bilateral puncture techniques in percutaneous kyphoplasty.
    Osteoporos Int. 2016;27:1849-55.
    PubMed     Text format     Abstract available


    April 2016
  304. WARD LM, Konji VN, Ma J
    The management of osteoporosis in children.
    Osteoporos Int. 2016.
    PubMed     Text format     Abstract available


  305. HILIGSMANN M, Ronda G, van der Weijden T, Boonen A, et al
    The development of a personalized patient education tool for decision making for postmenopausal women with osteoporosis.
    Osteoporos Int. 2016.
    PubMed     Text format     Abstract available


  306. HEANEY RP
    Achieving the protection of high peak bone mass.
    Osteoporos Int. 2016;27:1279-80.
    PubMed     Text format    


    March 2016
  307. NAYLOR KL, Lix LM, Hans D, Garg AX, et al
    Trabecular bone score in kidney transplant recipients.
    Osteoporos Int. 2016;27:1115-21.
    PubMed     Text format     Abstract available


  308. MAMAN E, Borderie D, Roux C, Briot K, et al
    Absence of recognition of low alkaline phosphatase level in a tertiary care hospital.
    Osteoporos Int. 2016;27:1251-4.
    PubMed     Text format     Abstract available


    February 2016
  309. WEAVER CM, Gordon CM, Janz KF, Kalkwarf HJ, et al
    The National Osteoporosis Foundation's position statement on peak bone mass development and lifestyle factors: a systematic review and implementation recommendations.
    Osteoporos Int. 2016.
    PubMed     Text format     Abstract available


    January 2016
  310. SI L, Winzenberg TM, Chen M, Jiang Q, et al
    Screening for osteoporosis in Chinese post-menopausal women: a health economic modelling study.
    Osteoporos Int. 2016.
    PubMed     Text format     Abstract available


  311. LEIB ES, Winzenrieth R
    Bone status in glucocorticoid-treated men and women.
    Osteoporos Int. 2016;27:39-48.
    PubMed     Text format     Abstract available


  312. NEUMANN T, Lodes S, Kastner B, Lehmann T, et al
    Trabecular bone score in type 1 diabetes--a cross-sectional study.
    Osteoporos Int. 2016;27:127-33.
    PubMed     Text format     Abstract available


  313. OTAIFY GA, Aglan MS, Ibrahim MM, Elnashar M, et al
    Zoledronic acid in children with osteogenesis imperfecta and Bruck syndrome: a 2-year prospective observational study.
    Osteoporos Int. 2016;27:81-92.
    PubMed     Text format     Abstract available


  314. HARVEY NC, Johansson H, Oden A, Karlsson MK, et al
    FRAX predicts incident falls in elderly men: findings from MrOs Sweden.
    Osteoporos Int. 2016;27:267-74.
    PubMed     Text format     Abstract available


    December 2015
  315. SILVERMAN SL, Adachi JD, Dennison E
    Bisphosphonate drug holidays: we reap what we sow.
    Osteoporos Int. 2015.
    PubMed     Text format    


    November 2015
  316. AVILA ML, Pullenayegum E, Williams S, Shammas A, et al
    Timing of low bone mineral density and predictors of bone mineral density trajectory in children on long-term warfarin: a longitudinal study.
    Osteoporos Int. 2015.
    PubMed     Text format     Abstract available


  317. CHEN F, Dai Z, Kang Y, Lv G, et al
    Effects of zoledronic acid on bone fusion in osteoporotic patients after lumbar fusion.
    Osteoporos Int. 2015.
    PubMed     Text format     Abstract available


    October 2015
  318. SATO H, Kondo N, Wada Y, Nakatsue T, et al
    The cumulative incidence of and risk factors for latent beaking in patients with autoimmune diseases taking long-term glucocorticoids and bisphosphonates.
    Osteoporos Int. 2015.
    PubMed     Text format     Abstract available


  319. EBINA K, Noguchi T, Hirao M, Hashimoto J, et al
    Effects of switching weekly alendronate or risedronate to monthly minodronate in patients with rheumatoid arthritis: a 12-month prospective study.
    Osteoporos Int. 2015.
    PubMed     Text format     Abstract available


    September 2015
  320. HWANG IR, Choi YK, Lee WK, Kim JG, et al
    Association between prolonged breastfeeding and bone mineral density and osteoporosis in postmenopausal women: KNHANES 2010-2011.
    Osteoporos Int. 2015.
    PubMed     Text format     Abstract available


    July 2015
  321. PAPAPOULOS S, Lippuner K, Roux C, Lin CJ, et al
    The effect of 8 or 5 years of denosumab treatment in postmenopausal women with osteoporosis: results from the FREEDOM Extension study.
    Osteoporos Int. 2015.
    PubMed     Text format     Abstract available


  322. ALBAUM JM, Levesque LE, Gershon AS, Liu G, et al
    Glucocorticoid-induced osteoporosis management among seniors, by year, sex, and indication, 1996-2012.
    Osteoporos Int. 2015.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Fractures is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: